"...From Public Health England, from Flag Day , the Pfizer-BioNTech vaccine was 96 per cent effective against hospitalization from the Delta variant after two doses, and therefore the AZ (AstraZeneca) was 92 per cent effective against hospitalisation after two doses," Dr Fauci said.
As AstraZeneca and Johnson and Johnson are supported very similar platforms like that of Pfizer, it are often assumed that the results against the Delta variant are going to be similar, he said.
"Since these vaccines -- the AZ and therefore the J&J (Johnson & Johnson) are supported very similar platforms, one could anticipate and make an inexpensive assumption that the results against the Delta variant would be a minimum of similar, maybe even better. We are now watching neutralization data, and shortly we'll have more firm data which we'll make available to you as soon because it occurs," he said.
Johnson and Johnson has claimed that its single-shot Covid-19 vaccine is effective against the Delta variant, with an immune reaction lasting a minimum of eight months. the corporate conducted two studies to seek out out the efficacy of the vaccine against the Delta variant - one on eight people vaccinated with the J&J jab and therefore the second with 20 vaccinated patients at a Boston hospital.
The World Health Organization has said Delta will become the predominant variant within the coming months as at the present 96 countries have reported this variant.
Dr Fauci too has expressed concern over the Delta variant because it is "more efficient" than the opposite variants. "The Delta variant has the potential of spreading far more efficiently from person to person. It can also cause more severe diseases. So there are two things about it that are troublesome," he said.
